Bellevue Life Sciences Acquisition Corp. Rights
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp… Read more
Bellevue Life Sciences Acquisition Corp. Rights (BLACR) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Bellevue Life Sciences Acquisition Corp. Rights (BLACR) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Bellevue Life Sciences Acquisition Corp. Rights - Net Assets Trend (None–None)
This chart illustrates how Bellevue Life Sciences Acquisition Corp. Rights's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bellevue Life Sciences Acquisition Corp. Rights (None–None)
The table below shows the annual net assets of Bellevue Life Sciences Acquisition Corp. Rights from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Bellevue Life Sciences Acquisition Corp. Rights's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Bellevue Life Sciences Acquisition Corp. Rights Competitors by Market Cap
The table below lists competitors of Bellevue Life Sciences Acquisition Corp. Rights ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ARINDO HOLDINGS (MAURITIUS) LIMITED (USD)
SEM:ARIN
|
$2.27K |
|
Plastic Additives JSC
VN:PGN
|
$2.27K |
|
Gia Tzoong Enterprise Co.,Ltd
TWO:5355
|
$2.27K |
|
CARBACID INVESTMENTS LTD
XNAI:CIL
|
$2.27K |
|
CRITICAL ELEMENTS (F12.SG)
STU:F12
|
$2.27K |
|
Singer Finance (Lanka) PLC
CM:SFINN0000
|
$2.26K |
|
Electro Force
NSE:ELEE
|
$2.26K |
|
ZAMBIAN BREWERIES PLC
LUSE:ZAMBREW
|
$2.26K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bellevue Life Sciences Acquisition Corp. Rights's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Bellevue Life Sciences Acquisition Corp. Rights's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Bellevue Life Sciences Acquisition Corp. Rights utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Bellevue Life Sciences Acquisition Corp. Rights's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bellevue Life Sciences Acquisition Corp. Rights (BLACR) | $- | N/A | N/A | $2.27K |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |